 |
PDBsum entry 3ccc
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of human dpp4 in complex with a benzimidazole derivative
|
|
Structure:
|
 |
Dipeptidyl peptidase 4. Chain: a, b, c, d. Synonym: dipeptidyl peptidase iv, dpp iv, t-cell activation antigen cd26, tp103, adenosine deaminase complexing protein 2, adabp. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Gene: dpp4, adcp2, cd26. Expressed in: spodoptera frugiperda. Expression_system_cell_line: sf9.
|
|
Resolution:
|
 |
|
2.71Å
|
R-factor:
|
0.204
|
R-free:
|
0.267
|
|
|
Authors:
|
 |
M.B.Wallace,R.J.Skene
|
|
Key ref:
|
 |
M.B.Wallace
et al.
(2008).
Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.
Bioorg Med Chem Lett,
18,
2362-2367.
PubMed id:
|
 |
|
Date:
|
 |
|
25-Feb-08
|
Release date:
|
21-Oct-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P27487
(DPP4_HUMAN) -
Dipeptidyl peptidase 4 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
766 a.a.
724 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.14.5
- dipeptidyl-peptidase Iv.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Release of an N-terminal dipeptide, Xaa-Xbb-|-Xcc, from a polypeptide, preferentially when Xbb is Pro, provided Xcc is neither Pro nor hydroxyproline.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Bioorg Med Chem Lett
18:2362-2367
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.
|
|
M.B.Wallace,
J.Feng,
Z.Zhang,
R.J.Skene,
L.Shi,
C.L.Caster,
D.B.Kassel,
R.Xu,
S.L.Gwaltney.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A novel series of non-covalent, benzimidazole-based inhibitors of DPP-4 has been
developed from a small fragment hit using structure-based drug design. A highly
versatile synthetic route was created for the development of SAR, which led to
the discovery of potent and selective inhibitors with excellent pharmaceutical
properties.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.W.Murray,
and
T.L.Blundell
(2010).
Structural biology in fragment-based drug design.
|
| |
Curr Opin Struct Biol,
20,
497-507.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |